LAS VEGAS, NV - August 12, 2025 (NEWMEDIAWIRE) - NeuralBase AI Ltd. (OTC: NBBI), operating under its enterprise brand BMP AI, is pleased to announce that the company has officially submitted its innovative HeartEase mobile application for review on the Google Play Store. This milestone marks a major step toward making HeartEase available to Android users worldwide.

The HeartEase app is designed to deliver advanced, AI-powered health and wellness support, empowering users with real-time insights and personalized guidance for heart health.

Following the Android release, the company will immediately proceed with final testing and submission of the iOS version to the Apple App Store, ensuring HeartEase is accessible to a broad global audience.

"We are thrilled to bring HeartEase to the Android community and look forward to its imminent launch. This is just the first step in our broader vision to make AI-driven healthcare support available to everyone, on every platform," stated Vighnesh Dobale, CEO of NeuralBase AI.

Once the review process by Google Play is complete and the app is published, NeuralBase will provide an additional update.

Additional information about NeuralBase AI Ltd. is available at https://www.neuralbase.ai or by visiting https://www.sec.gov.

About NEURALBASE AI LTD.

NeuralBase AI Ltd. (OTC: NBBI) is a publicly traded AI company focused on secure, scalable, and context-aware conversational systems and workflow automation. Through its BMP AI platform, currently in beta testing, the Company enables enterprises to streamline internal operations, enhance team collaboration, and improve productivity while maintaining compliance and data security.

Legal Disclaimer and Forward-Looking Statements

This press release contains forward-looking statements as defined under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements reflect current expectations, estimates, and projections of NeuralBase AI Ltd. (the “Company” or “NBBI”) based on assumptions and current market conditions. Forward-looking statements may include terms such as “aims,” “anticipates,” “expects,” “intends,” “plans,” “believes,” “may,” “will,” “could,” “should,” and similar expressions.

These statements relate, among other things, to the expected features and performance of the BMP AI platform; the timing and success of product development; potential industry applications; and overall strategic direction. All forward-looking statements are inherently subject to risks and uncertainties that may cause actual results to differ materially from those projected.

NeuralBase AI Ltd. is a fully reporting company with the U.S. Securities and Exchange Commission (SEC) and files annual and quarterly reports, current reports, and other required disclosures. All public filings and disclosures may be reviewed at the SEC’s EDGAR database at www.sec.gov. The Company trades on the OTC Markets under the ticker symbol NBBI.

This press release is not, and should not be construed as, an offer to sell or a solicitation of an offer to buy any securities of NeuralBase AI Ltd. in the United States or in any other jurisdiction. Offers and sales of securities, if any, will be made only pursuant to an effective registration statement or valid exemption under the U.S. Securities Act of 1933, as amended.

Investing in securities traded on the OTC Markets involves significant risk, including potential loss of principal, low liquidity, high volatility, and limited publicly available information. Shares traded on the OTC Markets may be more susceptible to market manipulation or price swings. Investors are strongly advised to conduct their own due diligence, consult a qualified investment advisor, and carefully review all SEC filings prior to making any investment decision.

Media Contact:
Vighnesh Dobale
Chief Executive Officer
ir@neuralbase.ai
(727) 314-3717

View the original release on www.newmediawire.com